Company intelligence / Profile preview

BioMedVC

Basel, Basel-Stadt, Switzerlandbiomedvc.com ↗

Ownership: Private
Development stage: Other

Overview

BioMedVC is an active Swiss early-stage venture capital fund focused on building and investing in promising European biotech startups with innovative science aimed at delivering better medicines for patients. It has supported numerous successful exits and acquisitions within its portfolio[1][2][3].

Industry: Investors

Partnerships

Portfolio includes partnerships via invested companies with major pharma/biotech firms such as Baxter International and Boston Scientific through acquisition events.

Beyond the preview

Go deeper on BioMedVC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioMedVC.

Explore the full profile